- December 13, 2025
-
-
Loading
Loading
Carole Dore-Falcone resigned as chief financial officer of GeoPharma last week, a regulatory filing shows. Dore-Falcone is also ending her service as a senior vice president, and as a member of the board of directors.
GeoPharma made drastic changes in early August, selling assets and restructuring debt in a complicated series of moves. And on Aug. 9, President Kotha Sekharam resigned.
In 2009, GeoPharma lost $26 million in net income, with $22 million in revenues earned.
